Our study provides the first evidence of the involvement of the apelin signaling pathway in pancreatic cancer development through the upregulation of oncogenes and glycolysis-related gene expression, thus promoting tumor cell growth and migration. The gene discussed is APLN; the disease is familial pancreatic carcinoma.